<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Skowera A</submitter><funding>National Institute for Health Research (NIHR)</funding><funding>Juvenile Diabetes Research Foundation</funding><funding>Wellcome Trust</funding><funding>Juvenile Diabetes Research Foundation (JDRF) Autoimmunity Centers Consortium</funding><pagination>916-925</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4557541</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(3)</volume><pubmed_abstract>Autoreactive CD8 T cells play a central role in the destruction of pancreatic islet β-cells that leads to type 1 diabetes, yet the key features of this immune-mediated process remain poorly defined. In this study, we combined high-definition polychromatic flow cytometry with ultrasensitive peptide-human leukocyte antigen class I tetramer staining to quantify and characterize β-cell-specific CD8 T cell populations in patients with recent-onset type 1 diabetes and healthy control subjects. Remarkably, we found that β-cell-specific CD8 T cell frequencies in peripheral blood were similar between subject groups. In contrast to healthy control subjects, however, patients with newly diagnosed type 1 diabetes displayed hallmarks of antigen-driven expansion uniquely within the β-cell-specific CD8 T</pubmed_abstract><journal>Diabetes</journal><pubmed_title>β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure.</pubmed_title><pmcid>PMC4557541</pmcid><funding_grant_id>100326/Z/12/Z</funding_grant_id><funding_grant_id>type 1 diabetes 217194</funding_grant_id><funding_grant_id>17-2012-352</funding_grant_id><funding_grant_id>1-2007-1803</funding_grant_id><funding_grant_id>100326</funding_grant_id><funding_grant_id>100327</funding_grant_id><pubmed_authors>Heck S</pubmed_authors><pubmed_authors>Skowera A</pubmed_authors><pubmed_authors>Sewell AK</pubmed_authors><pubmed_authors>McLaren JE</pubmed_authors><pubmed_authors>Price DA</pubmed_authors><pubmed_authors>Eichmann M</pubmed_authors><pubmed_authors>Bingley PJ</pubmed_authors><pubmed_authors>Dayan CM</pubmed_authors><pubmed_authors>Peakman M</pubmed_authors><pubmed_authors>Matthews KK</pubmed_authors><pubmed_authors>Kronenberg-Versteeg D</pubmed_authors><pubmed_authors>Powrie J</pubmed_authors><pubmed_authors>Miles JJ</pubmed_authors><pubmed_authors>Dolton G</pubmed_authors><pubmed_authors>Ladell K</pubmed_authors><pubmed_authors>Knight RR</pubmed_authors><pubmed_authors>Gostick E</pubmed_authors></additional><is_claimable>false</is_claimable><name>β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure.</name><description>Autoreactive CD8 T cells play a central role in the destruction of pancreatic islet β-cells that leads to type 1 diabetes, yet the key features of this immune-mediated process remain poorly defined. In this study, we combined high-definition polychromatic flow cytometry with ultrasensitive peptide-human leukocyte antigen class I tetramer staining to quantify and characterize β-cell-specific CD8 T cell populations in patients with recent-onset type 1 diabetes and healthy control subjects. Remarkably, we found that β-cell-specific CD8 T cell frequencies in peripheral blood were similar between subject groups. In contrast to healthy control subjects, however, patients with newly diagnosed type 1 diabetes displayed hallmarks of antigen-driven expansion uniquely within the β-cell-specific CD8 T</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Mar</publication><modification>2025-04-26T04:04:54.63Z</modification><creation>2019-03-27T01:57:42Z</creation></dates><accession>S-EPMC4557541</accession><cross_references><pubmed>25249579</pubmed><doi>10.2337/db14-0332</doi></cross_references></HashMap>